Latest filing published 19 May 2023 for Quest Diagnostics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Gail R. Wilensky across 3 companies, led by Unitedhealth Group Inc, Quest Diagnostics Inc and ViewRay, Inc. In total, 17 filings cover trades dated from 4 January 2016 to 17 May 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 19 May 2023, the filings show a share grant in Quest Diagnostics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations